NASDAQ:MLTX
Recent Insider Activity Could Benefit MoonLake Immunotherapeutics (MLTX)
MoonLake Immunotherapeutics’s recent filing unveils that its Chief Financial Officer Bodenstedt Matthias acquired Company’s shares for reported $98808.0 on Oct ...
Investing in MoonLake Immunotherapeutics (MLTX) Is Getting More Attractive
MoonLake Immunotherapeutics’s recent filing unveils that its Chief Financial Officer Bodenstedt Matthias acquired Company’s shares for reported $98808.0 on Oct ...
MoonLake Immunotherapeutics’s latest rating changes from various analysts
In a filing, MoonLake Immunotherapeutics revealed its Chief Financial Officer Bodenstedt Matthias acquired Company’s shares for reported $98808.0 on Oct ...
MLTX’s latest rating updates from top analysts.
MoonLake Immunotherapeutics’s recently made public that its Chief Financial Officer Bodenstedt Matthias acquired Company’s shares for reported $98808.0 on Oct ...
Analysts review MoonLake Immunotherapeutics’s rating
In a filing, MoonLake Immunotherapeutics revealed its Chief Financial Officer Bodenstedt Matthias acquired Company’s shares for reported $98808.0 on Oct ...
